2026-2031 Global Circulating Tumor DNA Diagnostics Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region
HNY Research projects that the Circulating Tumor DNA Diagnostics market size will grow from 14262.18 Million USD in 2025 to 20716.15 Million USD by 2031, at an estimated CAGR of 6.42%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 2724.08 Million USD, the Europe market size was 2638.5 Million USD, and the Asia market size was 2133.62 Million USD.
This report presents a detailed and holistic analysis of the global Circulating Tumor DNA Diagnostics market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Circulating Tumor DNA Diagnostics manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Grail, Inc.
Guardant Health, Inc.
Biodesix, Inc.
Exosome Diagnostics
Freenome Inc.
LungLife AI, Inc.
Inivata Ltd.
Personal Genome Diagnostics, Inc.
CellMax Life
By Type
Test Kits
Reagents
By Application
Hospitals
Diagnostics Laboratories
Research Laboratories
Academic Research Institutes
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
For 2025 regional market size, the North America market size was 2724.08 Million USD, the Europe market size was 2638.5 Million USD, and the Asia market size was 2133.62 Million USD.
This report presents a detailed and holistic analysis of the global Circulating Tumor DNA Diagnostics market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Circulating Tumor DNA Diagnostics manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.
By Market Players:
Grail, Inc.
Guardant Health, Inc.
Biodesix, Inc.
Exosome Diagnostics
Freenome Inc.
LungLife AI, Inc.
Inivata Ltd.
Personal Genome Diagnostics, Inc.
CellMax Life
By Type
Test Kits
Reagents
By Application
Hospitals
Diagnostics Laboratories
Research Laboratories
Academic Research Institutes
By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America
Points Covered in The Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
- The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
- To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
- Assess the production processes, major issues, and solutions to mitigate the development risk.
- To understand the most affecting driving and restraining forces in the market and its impact in the global market.
- Learn about the market strategies that are being adopted by leading respective organizations.
- To understand the future outlook and prospects for the market.
- Besides the standard structure reports, we also provide custom research according to specific requirements.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Global Market Size by Player 2020-2025
1.4 Global Market Size by Type in 2026-2031
1.4.1 Global Market Size by Type in 2026-2031
1.4.2 Test Kits
1.4.3 Reagents
1.5 Global Market Size by Application in 2026-2031
1.5.1 Global Market Size by Application in 2026-2031
1.5.2 Hospitals
1.5.3 Diagnostics Laboratories
1.5.4 Research Laboratories
1.5.5 Academic Research Institutes
1.6 Global Market Size by Region 2026-2031
1.6.1 Global Market Size Outlook 2026-2031
1.6.2 North America
1.6.3 East Asia
1.6.4 Europe
1.6.5 South Asia
1.6.6 Southeast Asia
1.6.7 Middle East
1.6.8 Africa
1.6.9 Oceania
1.6.10 South America
1.6.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS 2026
2.1 Manufacturing Cost Structure Analysis of Circulating Tumor DNA Diagnostics 2026
2.2 Industry Chain Structure Analysis of Circulating Tumor DNA Diagnostics 2026
3 MARKET COMPETITION ANALYSIS BY PLAYERS 2020-2025
3.1 Global Circulating Tumor DNA Diagnostics Production Capacity by Players 2020-2025
3.2 Global Circulating Tumor DNA Diagnostics Production Revenue by Players 2020-2025
3.3 Global Circulating Tumor DNA Diagnostics Ex-Factory Price by Players 2020-2025
4 MARKET COMPETITION ANALYSIS BY REGION 2020-2025
4.1 Global Circulating Tumor DNA Diagnostics Production by Region 2020-2025
4.1.1 Global Circulating Tumor DNA Diagnostics Production Volume by Region 2020-2025
4.1.2 Global Circulating Tumor DNA Diagnostics Production Revenue by Region 2020-2025
4.2 Global Circulating Tumor DNA Diagnostics Consumption Volume by Region 2020-2025
4.3 North America Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.3.1 North America Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.3.2 North America Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.3.3 North America Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.3.4 North America Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.4 East Asia Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.4.1 East Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.4.2 East Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.4.3 East Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.4.4 East Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.5 Europe Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.5.1 Europe Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.5.2 Europe Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.5.3 Europe Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.5.4 Europe Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.6 South Asia Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.6.1 South Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.6.2 South Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.6.3 South Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.6.4 South Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.7 Southeast Asia Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.7.1 Southeast Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.7.2 Southeast Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.7.3 Southeast Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.7.4 Southeast Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.8 Middle East Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.8.1 Middle East Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.8.2 Middle East Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.8.3 Middle East Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.8.4 Middle East Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.9 Africa Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.9.1 Africa Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.9.2 Africa Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.9.3 Africa Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.9.4 Africa Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.10 Oceania Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.10.1 Oceania Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.10.2 Oceania Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.10.3 Oceania Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.10.4 Oceania Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.11 South America Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.11.1 South America Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.11.2 South America Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.11.3 South America Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.11.4 South America Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
5 MARKET COMPETITION ANALYSIS BY TYPE (SALES VIEW) 2020-2031
5.1 Global Circulating Tumor DNA Diagnostics Historic Market Size by Type in 2020-2025
5.2 Global Circulating Tumor DNA Diagnostics Forecasted Market Size by Type in 2026-2031
6 MARKET COMPETITION ANALYSIS BY APPLICATION (CONSUMPTION VIEW) 2020-2031
6.1 Global Circulating Tumor DNA Diagnostics Historic Market Size by Application in 2020-2025
6.2 Global Circulating Tumor DNA Diagnostics Forecasted Market Size by Application in 2026-2031
7 LEADING COMPANY PROFILES AND KEY FIGURES IN CIRCULATING TUMOR DNA DIAGNOSTICS BUSINESS 2020-2025
7.1 Grail, Inc.
7.1.1 Grail, Inc. Company Profile
7.1.2 Grail, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.1.3 Grail, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.2 Guardant Health, Inc.
7.2.1 Guardant Health, Inc. Company Profile
7.2.2 Guardant Health, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.2.3 Guardant Health, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.3 Biodesix, Inc.
7.3.1 Biodesix, Inc. Company Profile
7.3.2 Biodesix, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.3.3 Biodesix, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.4 Exosome Diagnostics
7.4.1 Exosome Diagnostics Company Profile
7.4.2 Exosome Diagnostics Circulating Tumor DNA Diagnostics Product Specification
7.4.3 Exosome Diagnostics Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.5 Freenome Inc.
7.5.1 Freenome Inc. Company Profile
7.5.2 Freenome Inc. Circulating Tumor DNA Diagnostics Product Specification
7.5.3 Freenome Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.6 LungLife AI, Inc.
7.6.1 LungLife AI, Inc. Company Profile
7.6.2 LungLife AI, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.6.3 LungLife AI, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.7 Inivata Ltd.
7.7.1 Inivata Ltd. Company Profile
7.7.2 Inivata Ltd. Circulating Tumor DNA Diagnostics Product Specification
7.7.3 Inivata Ltd. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.8 Personal Genome Diagnostics, Inc.
7.8.1 Personal Genome Diagnostics, Inc. Company Profile
7.8.2 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.8.3 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.9 CellMax Life
7.9.1 CellMax Life Company Profile
7.9.2 CellMax Life Circulating Tumor DNA Diagnostics Product Specification
7.9.3 CellMax Life Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
8 MARKET FORECAST ANALYSIS ON PRODUCTION AND SUPPLY BY REGION 2026-2031
8.1 Global Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
8.2 Global Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
8.3 Global Forecasted Production Volume of Circulating Tumor DNA Diagnostics by Region 2026-2031
8.3.1 North America Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.2 East Asia Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.3 Europe Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.4 South Asia Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.5 Southeast Asia Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.6 Middle East Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.7 Africa Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.8 Oceania Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.9 South America Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.10 Rest of the World Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.4 Global Forecasted Sales by Type and Consumption by Application in 2026-2031
8.4.1 Global Forecasted Sales Volume, Sales Revenue and Sales Price by Type in 2026-2031
8.4.2 Global Forecasted Consumption Volume and Consumption Value by Application in 2026-2031
9 MARKET FORECAST ANALYSIS ON CONSUMPTION AND DEMAND BY REGION 2026-2031
9.1 North America Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.2 East Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.3 Europe Market Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.4 South Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.5 Southeast Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.6 Middle East Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.7 Africa Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.8 Oceania Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.9 South America Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.10 Rest of the World Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS ANALYSIS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS ANALYSIS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Who Trust HNY Research
13.4 Disclaimer
Research Methodology
1.1 Study Scope
1.2 Key Market Segments
1.3 Global Market Size by Player 2020-2025
1.4 Global Market Size by Type in 2026-2031
1.4.1 Global Market Size by Type in 2026-2031
1.4.2 Test Kits
1.4.3 Reagents
1.5 Global Market Size by Application in 2026-2031
1.5.1 Global Market Size by Application in 2026-2031
1.5.2 Hospitals
1.5.3 Diagnostics Laboratories
1.5.4 Research Laboratories
1.5.5 Academic Research Institutes
1.6 Global Market Size by Region 2026-2031
1.6.1 Global Market Size Outlook 2026-2031
1.6.2 North America
1.6.3 East Asia
1.6.4 Europe
1.6.5 South Asia
1.6.6 Southeast Asia
1.6.7 Middle East
1.6.8 Africa
1.6.9 Oceania
1.6.10 South America
1.6.11 Rest of the World
2 MANUFACTURING COST STRUCTURE ANALYSIS 2026
2.1 Manufacturing Cost Structure Analysis of Circulating Tumor DNA Diagnostics 2026
2.2 Industry Chain Structure Analysis of Circulating Tumor DNA Diagnostics 2026
3 MARKET COMPETITION ANALYSIS BY PLAYERS 2020-2025
3.1 Global Circulating Tumor DNA Diagnostics Production Capacity by Players 2020-2025
3.2 Global Circulating Tumor DNA Diagnostics Production Revenue by Players 2020-2025
3.3 Global Circulating Tumor DNA Diagnostics Ex-Factory Price by Players 2020-2025
4 MARKET COMPETITION ANALYSIS BY REGION 2020-2025
4.1 Global Circulating Tumor DNA Diagnostics Production by Region 2020-2025
4.1.1 Global Circulating Tumor DNA Diagnostics Production Volume by Region 2020-2025
4.1.2 Global Circulating Tumor DNA Diagnostics Production Revenue by Region 2020-2025
4.2 Global Circulating Tumor DNA Diagnostics Consumption Volume by Region 2020-2025
4.3 North America Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.3.1 North America Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.3.2 North America Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.3.3 North America Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.3.4 North America Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.4 East Asia Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.4.1 East Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.4.2 East Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.4.3 East Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.4.4 East Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.5 Europe Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.5.1 Europe Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.5.2 Europe Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.5.3 Europe Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.5.4 Europe Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.6 South Asia Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.6.1 South Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.6.2 South Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.6.3 South Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.6.4 South Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.7 Southeast Asia Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.7.1 Southeast Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.7.2 Southeast Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.7.3 Southeast Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.7.4 Southeast Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.8 Middle East Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.8.1 Middle East Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.8.2 Middle East Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.8.3 Middle East Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.8.4 Middle East Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.9 Africa Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.9.1 Africa Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.9.2 Africa Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.9.3 Africa Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.9.4 Africa Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.10 Oceania Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.10.1 Oceania Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.10.2 Oceania Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.10.3 Oceania Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.10.4 Oceania Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
4.11 South America Circulating Tumor DNA Diagnostics Market Competition Analysis 2020-2025
4.11.1 South America Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
4.11.2 South America Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
4.11.3 South America Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
4.11.4 South America Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
5 MARKET COMPETITION ANALYSIS BY TYPE (SALES VIEW) 2020-2031
5.1 Global Circulating Tumor DNA Diagnostics Historic Market Size by Type in 2020-2025
5.2 Global Circulating Tumor DNA Diagnostics Forecasted Market Size by Type in 2026-2031
6 MARKET COMPETITION ANALYSIS BY APPLICATION (CONSUMPTION VIEW) 2020-2031
6.1 Global Circulating Tumor DNA Diagnostics Historic Market Size by Application in 2020-2025
6.2 Global Circulating Tumor DNA Diagnostics Forecasted Market Size by Application in 2026-2031
7 LEADING COMPANY PROFILES AND KEY FIGURES IN CIRCULATING TUMOR DNA DIAGNOSTICS BUSINESS 2020-2025
7.1 Grail, Inc.
7.1.1 Grail, Inc. Company Profile
7.1.2 Grail, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.1.3 Grail, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.2 Guardant Health, Inc.
7.2.1 Guardant Health, Inc. Company Profile
7.2.2 Guardant Health, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.2.3 Guardant Health, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.3 Biodesix, Inc.
7.3.1 Biodesix, Inc. Company Profile
7.3.2 Biodesix, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.3.3 Biodesix, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.4 Exosome Diagnostics
7.4.1 Exosome Diagnostics Company Profile
7.4.2 Exosome Diagnostics Circulating Tumor DNA Diagnostics Product Specification
7.4.3 Exosome Diagnostics Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.5 Freenome Inc.
7.5.1 Freenome Inc. Company Profile
7.5.2 Freenome Inc. Circulating Tumor DNA Diagnostics Product Specification
7.5.3 Freenome Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.6 LungLife AI, Inc.
7.6.1 LungLife AI, Inc. Company Profile
7.6.2 LungLife AI, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.6.3 LungLife AI, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.7 Inivata Ltd.
7.7.1 Inivata Ltd. Company Profile
7.7.2 Inivata Ltd. Circulating Tumor DNA Diagnostics Product Specification
7.7.3 Inivata Ltd. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.8 Personal Genome Diagnostics, Inc.
7.8.1 Personal Genome Diagnostics, Inc. Company Profile
7.8.2 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Diagnostics Product Specification
7.8.3 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
7.9 CellMax Life
7.9.1 CellMax Life Company Profile
7.9.2 CellMax Life Circulating Tumor DNA Diagnostics Product Specification
7.9.3 CellMax Life Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
8 MARKET FORECAST ANALYSIS ON PRODUCTION AND SUPPLY BY REGION 2026-2031
8.1 Global Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
8.2 Global Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
8.3 Global Forecasted Production Volume of Circulating Tumor DNA Diagnostics by Region 2026-2031
8.3.1 North America Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.2 East Asia Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.3 Europe Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.4 South Asia Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.5 Southeast Asia Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.6 Middle East Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.7 Africa Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.8 Oceania Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.9 South America Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.3.10 Rest of the World Forecasted Production of Circulating Tumor DNA Diagnostics 2026-2031
8.4 Global Forecasted Sales by Type and Consumption by Application in 2026-2031
8.4.1 Global Forecasted Sales Volume, Sales Revenue and Sales Price by Type in 2026-2031
8.4.2 Global Forecasted Consumption Volume and Consumption Value by Application in 2026-2031
9 MARKET FORECAST ANALYSIS ON CONSUMPTION AND DEMAND BY REGION 2026-2031
9.1 North America Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.2 East Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.3 Europe Market Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.4 South Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.5 Southeast Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.6 Middle East Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.7 Africa Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.8 Oceania Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.9 South America Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
9.10 Rest of the World Forecasted Consumption of Circulating Tumor DNA Diagnostics by Country
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS ANALYSIS
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 MARKET DYNAMICS ANALYSIS
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Who Trust HNY Research
13.4 Disclaimer
Research Methodology
LIST OF TABLES
Table Global Market Size in Production Revenue by Player 2020-2025
Table Global Market Size in Sales Revenue by Type in 2026-2031
Table Global Market Size in Consumption Value by Application in 2026-2031
Table Global Circulating Tumor DNA Diagnostics Production Capacity by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Volume by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Volume Market Share by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Revenue by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Revenue Share by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Ex-Factory Price of Key Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Volume by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Volume Market Share by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Revenue by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Revenue Market Share by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Consumption Volume by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Consumption Volume Market Share by Region 2020-2025
Table North America Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table North America Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table East Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table East Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Europe Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Europe Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table South Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table South Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Southeast Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Southeast Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Middle East Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Middle East Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Africa Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Africa Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Oceania Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Oceania Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table South America Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table South America Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Global Circulating Tumor DNA Diagnostics Historic Sales Revenue by Type in 2020-2025
Table Global Circulating Tumor DNA Diagnostics Historic Sales Revenue Market Share by Type in 2020-2025
Table Global Circulating Tumor DNA Diagnostics Forecasted Sales Revenue by Type in 2026-2031
Table Global Circulating Tumor DNA Diagnostics Forecasted Sales Revenue Market Share by Type in 2026-2031
Table Global Circulating Tumor DNA Diagnostics Historic Consumption Value by Application in 2020-2025
Table Global Circulating Tumor DNA Diagnostics Historic Cosumption Value Market Share by Application in 2020-2025
Table Global Circulating Tumor DNA Diagnostics Forecasted Cononumption Value by Application in 2026-2031
Table Global Circulating Tumor DNA Diagnostics Forecasted Cononumption Value Market Share by Application in 2026-2031
Table Grail, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Guardant Health, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Biodesix, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Exosome Diagnostics Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Freenome Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table LungLife AI, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Inivata Ltd. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Personal Genome Diagnostics, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table CellMax Life Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Global Forecasted Production Volume of Circulating Tumor DNA Diagnostics by Region 2026-2031
Table Global Forecasted Sales Volume by Type in 2026-2031
Table Global Forecasted Sales Volume Market Share by Type in 2026-2031
Table Global Forecasted Sales Revenue by Type in 2026-2031
Table Global Forecasted Sales Revenue Market Share by Type in 2026-2031
Table Global Forecasted Sales Price by Type in 2026-2031
Table Global Forecasted Consumption Volume by Application in 2026-2031
Table Global Forecasted Consumption Value by Application in 2026-2031
Table Market Key Trends
Table Key Opportunities and Drivers: Impact Analysis 2026-2031
Table Key Challenges
Table Research Programs/Design for This Report
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Table Global Market Size in Production Revenue by Player 2020-2025
Table Global Market Size in Sales Revenue by Type in 2026-2031
Table Global Market Size in Consumption Value by Application in 2026-2031
Table Global Circulating Tumor DNA Diagnostics Production Capacity by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Volume by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Volume Market Share by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Revenue by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Revenue Share by Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Ex-Factory Price of Key Players 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Volume by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Volume Market Share by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Revenue by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Production Revenue Market Share by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Consumption Volume by Region 2020-2025
Table Global Circulating Tumor DNA Diagnostics Consumption Volume Market Share by Region 2020-2025
Table North America Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table North America Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table East Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table East Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Europe Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Europe Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table South Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table South Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Southeast Asia Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Southeast Asia Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Middle East Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Middle East Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Africa Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Africa Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Oceania Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table Oceania Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table South America Circulating Tumor DNA Diagnostics Sales Volume by Key Players 2020-2025
Table South America Circulating Tumor DNA Diagnostics Production, Consumption, Import and Export 2020-2025
Table Global Circulating Tumor DNA Diagnostics Historic Sales Revenue by Type in 2020-2025
Table Global Circulating Tumor DNA Diagnostics Historic Sales Revenue Market Share by Type in 2020-2025
Table Global Circulating Tumor DNA Diagnostics Forecasted Sales Revenue by Type in 2026-2031
Table Global Circulating Tumor DNA Diagnostics Forecasted Sales Revenue Market Share by Type in 2026-2031
Table Global Circulating Tumor DNA Diagnostics Historic Consumption Value by Application in 2020-2025
Table Global Circulating Tumor DNA Diagnostics Historic Cosumption Value Market Share by Application in 2020-2025
Table Global Circulating Tumor DNA Diagnostics Forecasted Cononumption Value by Application in 2026-2031
Table Global Circulating Tumor DNA Diagnostics Forecasted Cononumption Value Market Share by Application in 2026-2031
Table Grail, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Guardant Health, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Biodesix, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Exosome Diagnostics Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Freenome Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table LungLife AI, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Inivata Ltd. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Personal Genome Diagnostics, Inc. Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table CellMax Life Circulating Tumor DNA Diagnostics Production Capacity, Revenue, Price and Gross Margin 2020-2025
Table Global Forecasted Production Volume of Circulating Tumor DNA Diagnostics by Region 2026-2031
Table Global Forecasted Sales Volume by Type in 2026-2031
Table Global Forecasted Sales Volume Market Share by Type in 2026-2031
Table Global Forecasted Sales Revenue by Type in 2026-2031
Table Global Forecasted Sales Revenue Market Share by Type in 2026-2031
Table Global Forecasted Sales Price by Type in 2026-2031
Table Global Forecasted Consumption Volume by Application in 2026-2031
Table Global Forecasted Consumption Value by Application in 2026-2031
Table Market Key Trends
Table Key Opportunities and Drivers: Impact Analysis 2026-2031
Table Key Challenges
Table Research Programs/Design for This Report
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
LIST OF FIGURES
Figure Global Market Share in Sales Revenue by Type in 2025
Figure Test Kits Features
Figure Reagents Features
Figure Global Market Share in Consumption Value by Application in 2025
Figure Hospitals Case Studies
Figure Diagnostics Laboratories Case Studies
Figure Research Laboratories Case Studies
Figure Academic Research Institutes Case Studies
Figure Global Market Size in Sales Revenue Outlook 2026-2031
Figure North America Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure East Asia Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Europe Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure South Asia Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure South America Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Middle East Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Africa Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Oceania Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure South America Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Rest of the World Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Manufacturing Cost Structure Analysis of Circulating Tumor DNA Diagnostics 2026
Figure Industry Chain Structure Analysis of Circulating Tumor DNA Diagnostics 2026
Figure Global Circulating Tumor DNA Diagnostics Production Volume Market Share by Region in 2025
Figure Global Circulating Tumor DNA Diagnostics Production Revenue Market Share by Region in 2025
Figure North America Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure North America Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure East Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure East Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Europe Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Europe Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure South Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure South Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Southeast Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Southeast Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Middle East Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Middle East Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Africa Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Africa Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Oceania Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Oceania Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure South America Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure South America Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Grail, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure Guardant Health, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure Biodesix, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure Exosome Diagnostics Circulating Tumor DNA Diagnostics Product Specification
Figure Freenome Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure LungLife AI, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure Inivata Ltd. Circulating Tumor DNA Diagnostics Product Specification
Figure Personal Genome Diagnostics, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure CellMax Life Circulating Tumor DNA Diagnostics Product Specification
Figure Global Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Global Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure North America Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure North America Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure East Asia Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure East Asia Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Europe Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Europe Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure South Asia Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure South Asia Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Southeast Asia Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Southeast Asia Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Middle East Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Middle East Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Africa Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Africa Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Oceania Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Oceania Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure South America Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure South America Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Rest of the World Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Rest of the World Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure North America Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure North America Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure East Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure East Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Europe Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Europe Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure South Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure South Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Southeast Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Southeast Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Middle East Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Middle East Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Africa Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Africa Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Oceania Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Oceania Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure South America Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure South America Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Rest of the World Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Rest of the World Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Channels of Distribution
Figure Porter's Five Forces Analysis
Figure Key Executives Interviewed
Figure Global Market Share in Sales Revenue by Type in 2025
Figure Test Kits Features
Figure Reagents Features
Figure Global Market Share in Consumption Value by Application in 2025
Figure Hospitals Case Studies
Figure Diagnostics Laboratories Case Studies
Figure Research Laboratories Case Studies
Figure Academic Research Institutes Case Studies
Figure Global Market Size in Sales Revenue Outlook 2026-2031
Figure North America Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure East Asia Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Europe Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure South Asia Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure South America Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Middle East Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Africa Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Oceania Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure South America Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Rest of the World Circulating Tumor DNA Diagnostics Sales Revenue and Growth Rate 2026-2031
Figure Manufacturing Cost Structure Analysis of Circulating Tumor DNA Diagnostics 2026
Figure Industry Chain Structure Analysis of Circulating Tumor DNA Diagnostics 2026
Figure Global Circulating Tumor DNA Diagnostics Production Volume Market Share by Region in 2025
Figure Global Circulating Tumor DNA Diagnostics Production Revenue Market Share by Region in 2025
Figure North America Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure North America Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure East Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure East Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Europe Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Europe Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure South Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure South Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Southeast Asia Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Southeast Asia Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Middle East Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Middle East Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Africa Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Africa Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Oceania Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure Oceania Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure South America Circulating Tumor DNA Diagnostics Production Volume Analysis 2020-2025
Figure South America Circulating Tumor DNA Diagnostics Production Revenue Analysis 2020-2025
Figure Grail, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure Guardant Health, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure Biodesix, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure Exosome Diagnostics Circulating Tumor DNA Diagnostics Product Specification
Figure Freenome Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure LungLife AI, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure Inivata Ltd. Circulating Tumor DNA Diagnostics Product Specification
Figure Personal Genome Diagnostics, Inc. Circulating Tumor DNA Diagnostics Product Specification
Figure CellMax Life Circulating Tumor DNA Diagnostics Product Specification
Figure Global Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Global Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure North America Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure North America Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure East Asia Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure East Asia Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Europe Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Europe Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure South Asia Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure South Asia Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Southeast Asia Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Southeast Asia Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Middle East Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Middle East Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Africa Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Africa Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Oceania Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Oceania Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure South America Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure South America Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure Rest of the World Forecasted Production Capacity of Circulating Tumor DNA Diagnostics 2026-2031
Figure Rest of the World Forecasted Production Revenue of Circulating Tumor DNA Diagnostics 2026-2031
Figure North America Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure North America Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure East Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure East Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Europe Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Europe Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure South Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure South Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Southeast Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Southeast Asia Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Middle East Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Middle East Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Africa Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Africa Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Oceania Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Oceania Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure South America Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure South America Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Rest of the World Forecasted Consumption of Circulating Tumor DNA Diagnostics 2026-2031
Figure Rest of the World Forecasted Consumption of Circulating Tumor DNA Diagnostics 2031 by Country
Figure Channels of Distribution
Figure Porter's Five Forces Analysis
Figure Key Executives Interviewed
